Viewing nowHusimba Tablet (Simvastatin)
Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.

MFDS item code 200200214 · Notified 2002.12.18 · Insurance code 649101780
Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; reduction of cardiovascular risk
This medication helps reduce the risk of cardiovascular disease. It is used to decrease the risk of death from coronary heart disease, non-fatal myocardial infarction, and the occurrence of stroke in adult patients with a history of coronary heart disease, diabetes, peripheral vascular disease, or stroke. It also improves cholesterol and triglyceride levels and increases HDL cholesterol in patients with primary and mixed hyperlipidemia, thus maintaining healthy blood lipid levels. In particular, it is effective in lowering cholesterol levels in pediatric and adolescent patients with heterozygous familial hypercholesterolemia who have a family history or risk factors, when used in combination with a diet. Therefore, this drug is used to protect cardiovascular health and improve dyslipidemia conditions, including hyperlipidemia.
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5 ~ 40 mg of this medicine once daily in the evening. Adjust the dose appropriately according to the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer to the information below for the recommended dose in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Drug Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this medicine once daily in the evening. This medicine should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In elderly patients, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg per day. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg per day. (6) Use in patients with renal impairment Because this medicine is not substantially excreted by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start treatment at 5 mg per day and monitor carefully.
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dosage range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.
This medication can cause myopathy or rhabdomyolysis. The risk is particularly higher when taking a high dose of 80 mg, so caution is needed. Patients with an allergy to this medication, severely impaired liver function, pregnant or nursing women, and those taking it with certain strong medications should not use this medication. Patients with weakened liver or kidney function, hypothyroidism or a history of muscle disease, elderly patients, and women should be more cautious when taking this medication. If muscle pain, weakness, or unusual symptoms occur during treatment, immediately inform a doctor and discontinue the medication if necessary. This medication may affect liver function, so regular liver function tests are important. If any symptoms of liver dysfunction occur, consult a medical professional immediately. This medication can interact with other drugs, so it is essential to discuss with a doctor, especially when taking certain antibiotics, antifungals, immunosuppressants, calcium channel blockers, nicotinic acid, etc., and adjustments in dosage or discontinuation may be needed. Pregnant women or those who may become pregnant should strictly avoid taking this medication, and if pregnancy is confirmed while on the medication, it should be stopped immediately and consultation with a healthcare professional is necessary. Nursing mothers are advised to discontinue breastfeeding while taking this medication. The use of this medication is limited in children and adolescents, especially it is not safe for patients under 10 years old. Elderly patients may have higher blood concentrations of this medication, so dosage adjustments and monitoring for side effects are required. Excessive intake of grapefruit juice or grapefruit products should be avoided while on this medication, as it may increase the medication’s concentration and raise the risk of side effects. Patients taking this medication must inform their healthcare provider when being prescribed new medications. In case of overdose, general emergency treatments should be performed, and since there is no specific antidote, immediate medical attention is required. Keep out of reach of children, and store in the original container to prevent misuse and degradation of the medication's quality.
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1°C and 30°C to safely preserve the medication's efficacy.
Brownish yellow oval film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Daehwa Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.